KMSTF

Quote

Short

News

Articles

Message Board

Kadimastem (OTCMKTS : KMSTF ) News

News Releases

KMSTF News Releases

October 29, 2025 06:22:55 am

SeekingAlpha

NLS Pharmaceutics to execute 1-for-10 reverse share split

October 29, 2025 03:53:00 am

PR Newswire

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares

September 10, 2025 06:00:00 am

PR Newswire

Kadimastem and NLS Pharmaceutics Announce Effectiveness of SEC Registration Statement in Connection with Proposed Merger

September 04, 2025 07:38:00 am

PR Newswire

NLS Pharmaceutics and Kadimastem announce a Hong Kong Patent Covering Cell-Selection and Enrichment Technology for IsletRx for Diabetes Patients

July 17, 2025 07:00:00 am

PR Newswire

NLS Pharmaceutics Highlights Continued Progress in iTOL-102 Diabetes Program as BIRD Foundation Approves Additional Milestone Payment to Kadimastem and iTolerance for Continued Co-Development of Type 1 Diabetes Cell Therapy

June 16, 2025 07:00:00 am

PR Newswire

NLS Pharmaceutics CEO Issues Letter to Shareholders

April 15, 2025 09:00:00 am

PR Newswire

NLS Pharmaceutics Announces Positive Results from Study KO-943 Demonstrating Mazindol Reduces Fentanyl-Induced Reward in Animal Models

January 28, 2025 07:30:00 am

PR Newswire

NLS Pharmaceutics Announces the Launch of a Preclinical Program for Mazindol ER in the Treatment of Fentanyl Dependence

January 16, 2025 09:32:00 am

PR Newswire

Kadimastem Calls for a Special General Meeting of Shareholders to Approve the Merger with NLS

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account